CC0000: Color is not claimed as a feature of the mark.
DM0000: The mark consists of "ARISAPH" in bold, capitalized letters, and "CREATING SMART MEDICINES" in a smaller, lowercased font underneath. To the left of "ARISAPH" is a stylized "A", without the horizontal line. Above and to either side of the stylized "A" are three stylized atomic particles. The particles are spaced to form an apparent second stylized "A" using the space between the particles and the first stylized "A".
GS0051: Pharmacological preparations and substances for the treatment of diabetes and atherosclerosis
Case File Event Statements
11/19/2021 - 3 years ago
52 - CANCELLED SEC. 8 (6-YR)Type:C8..
3/17/2020 - 4 years ago
51 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILEDType:REM1
3/17/2015 - 9 years ago
50 - REGISTERED-PRINCIPAL REGISTERType:R.PR
2/12/2015 - 10 years ago
49 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILEDType:SUNA
2/11/2015 - 10 years ago
48 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTEDType:CNPR
2/10/2015 - 10 years ago
47 - EXAMINER'S AMENDMENT ENTEREDType:XAEC
2/10/2015 - 10 years ago
46 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILEDType:GNEN
2/10/2015 - 10 years ago
45 - EXAMINERS AMENDMENT E-MAILEDType:GNEA
2/10/2015 - 10 years ago
44 - SU-EXAMINER'S AMENDMENT WRITTENType:SNEA
2/9/2015 - 10 years ago
43 - ASSIGNED TO EXAMINERType:DOCK
5/21/2014 - 10 years ago
42 - STATEMENT OF USE PROCESSING COMPLETEType:SUPC